Case number 2020-1723
Amarin Pharma, Inc. v. Hikma Pharmaceuticals USA > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Apr 23, 2021 | 0 | AMARIN PHARMA, INC. v. HIKMA PHARMACEUTICALS USA [RULE 36 JUDGMENT] [nonprecedential] (0) |
| Feb 17, 2021 | 92 | Petition for writ of certiorari filed on 02/11/2021 in the U.S. Supreme Court. No.: 20-1119, Inc. Amarin Pharma v. Hikma Pharmaceuticals USA Inc. [757210] [JCP] [Entered: 02/18/2021 07:29 PM] (1) |
| Nov 12, 2020 | 91 | Mandate issued to the United States District Court for the District of Nevada. Service as of this date by the Clerk of Court. [734979] [20-1723, 20-1901] [MJL] [Entered: 11/12/2020 09:05 AM] (1) |
| Nov 4, 2020 | 90 | ORDER filed denying [79] petition for panel rehearing, for en banc rehearing filed by Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Limited. By: En Banc (Per Curiam). Service as of this date by the Clerk of Court. [733476] [JAB] [Entered: 11/04/2020 08:59 AM] (2) |
| Oct 20, 2020 | 89 | AMICUS BRIEF FILED on Petition by Biotechnology Innovation Organization. Service: 10/16/2020 by email. [730143] [JAB] [Entered: 10/20/2020 11:13 AM] (20) |
| Oct 20, 2020 | 88 | ORDER filed granting motion leave to file amicus brief on en banc or rehearing petition [87] filed by Amicus Curiae Biotechnology Innovation Organization. By: Per Curiam. Service as of this date by the Clerk of Court. [730142] [JAB] [Entered: 10/20/2020 11:09 AM] (2) |
| Oct 16, 2020 | 87 | MOTION of Amicus Curiae Biotechnology Innovation Organization for leave to file an amicus curiae brief. Service: 10/16/2020 by email. [729532] [20-1723] [Rachel Elsby] [Entered: 10/16/2020 04:48 PM] (28) |
| Oct 13, 2020 | 86 | ORDER filed denying EPADI II's motions for leave to file an amicus brief in support of rehearing [82] and for leave to file a separate appendix [83]. By: Per Curiam. Service as of this date by the Clerk of Court. [728176] [MJL] [Entered: 10/13/2020 12:39 PM] (2) |
| Oct 8, 2020 | 85 | Certificate of Interest for EPADI II. Service: 10/08/2020 by email. [727538] [20-1723] [Michael Kasanoff] [Entered: 10/08/2020 02:00 AM] (3) |
| Oct 8, 2020 | 84 | Entry of appearance for Michael S. Kasanoff as counsel for EPADI II. Service: 10/08/2020 by email. [727537] [20-1723]--[Edited 10/08/2020 by JAB to correct filer] [Michael Kasanoff] [Entered: 10/08/2020 01:53 AM] (2) |
| Oct 8, 2020 | 83 | MOTION of EPADI II leave to file a supplemental appendix. Service: 10/08/2020 by email. [727536] [20-1723] [Michael Kasanoff] [Entered: 10/08/2020 01:51 AM] (6) |
| Oct 8, 2020 | 82 | MOTION of EPADI II for leave to file amicus brief in support of Amarin on petition for panel rehearing [79], petition for en banc rehearing [79]. Service: 10/08/2020 by email. [727535] [20-1723] [Michael Kasanoff] [Entered: 10/08/2020 01:50 AM] (7) |
| Oct 8, 2020 | 81 | COMBINED OPENING BRIEF & APPX (FCR 30(d)) FILED by EPADI II. Service: 10/08/2020 by email. [727534] [20-1723]. The motions for leave to file this proposed brief and appendix have been denied. See Doc. No. [86]. [Michael Kasanoff] [Entered: 10/08/2020 01:46 AM] (0) |
| Oct 6, 2020 | 80 | 18 paper copies of Doc. No. [79] received from Appellants Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Limited. [727079] [JAB] [Entered: 10/06/2020 03:19 PM] (0) |
| Oct 2, 2020 | 79 | Petition for panel rehearing, for en banc rehearing filed by Appellants Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Limited. Service: 10/02/2020 by email. [726088] [20-1723] [Jonathan Singer] [Entered: 10/02/2020 10:37 AM] (30) |
| Sep 3, 2020 | 78 | JUDGMENT. Affirmed. Issued pursuant to Federal Circuit Rule 36. Terminated on the merits after oral argument. COSTS: Costs taxed against Appellant(s). Mandate to issue in due course. For information regarding costs, petitions for rehearing, and petitions for writs of certiorari click here. [719299] [20-1723, 20-1901] [JCA] [Entered: 09/03/2020 09:09 AM] (3) |
| Sep 2, 2020 | 77 | Submitted after ORAL ARGUMENT by Jonathan Elliot Singer for Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Limited and Charles B. Klein for Hikma Pharmaceuticals USA Inc., Hikma Pharmaceuticals International Limited, Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd. Panel: Judge: Dyk , Judge: Reyna , Judge: Hughes.Oral Argument Audio available here. [719122] [JAB] [Entered: 09/02/2020 12:13 PM] (0) |
| Aug 17, 2020 | 76 | Response to notice of oral argument from the Appellees Hikma Pharmaceuticals International Limited, Hikma Pharmaceuticals USA Inc., Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd.. Service: 08/17/2020 by email. [715298] [20-1723] [Charles Klein] [Entered: 08/17/2020 02:46 PM] (1) |
| Aug 17, 2020 | 75 | Response to notice of oral argument from the Appellants Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Limited. Service: 08/17/2020 by email. [715291] [20-1723] [Jonathan Singer] [Entered: 08/17/2020 02:35 PM] (1) |
| Aug 17, 2020 | 74 | Clerk's letter to Appellants Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited and Appellees Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Hikma Pharmaceuticals International Limited and Hikma Pharmaceuticals USA Inc. regarding Telephonic Argument Orientation. Service as of this date by the Clerk of Court. [715275] [JAB] [Entered: 08/17/2020 02:10 PM] (0) |
| Aug 7, 2020 | 73 | Letter from Appellants Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Limited regarding Appendix Citations in Opening Brief. Service: 08/07/2020 by email. [713309] [20-1723] [Jonathan Singer] [Entered: 08/07/2020 11:21 AM] (1) |
| Jul 21, 2020 | 72 | 7 paper copies of the Amicus Brief [43] received from Amicus Curiae Aimed Alliance. [709108] [CJF] [Entered: 07/22/2020 08:11 AM] (0) |
| Jul 21, 2020 | 71 | NOTICE OF TELEPHONIC ORAL ARGUMENT. Panel: 2009F. Case scheduled September 2, 2020. Response to Notice of Oral Argument due: 08/17/2020. The Clerk's Office will provide additional instructions to counsel at least one week ahead of argument. Please review the attached Notice. The response to notice of oral argument form can be found here. The Oral Argument Guide can be found here. [708925] [JAB] [Entered: 07/21/2020 01:21 PM] (1) |
| Jul 20, 2020 | 70 | Notice from Appellees Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Hikma Pharmaceuticals International Limited and Hikma Pharmaceuticals USA Inc. regarding conflicts with oral argument. Service: 07/20/2020 by email. [708744] [20-1723] [Constance Huttner] [Entered: 07/20/2020 09:20 PM] (1) |
| Jul 20, 2020 | 69 | Notice from Appellees Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Hikma Pharmaceuticals International Limited and Hikma Pharmaceuticals USA Inc. regarding conflicts with oral argument. None. Service: 07/20/2020 by email. [708736] [20-1723] [Charles Klein] [Entered: 07/20/2020 07:46 PM] (1) |
| Jul 17, 2020 | 68 | 6 paper copies of the Corrected Opening Brief [32] received from Appellants Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Limited. [708624] [CJF] [Entered: 07/20/2020 04:10 PM] (0) |
| Jul 17, 2020 | 67 | 6 paper copies of the Reply Brief [50] received from Appellants Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Limited. [708617] [CJF] [Entered: 07/20/2020 04:06 PM] (0) |
| Jul 17, 2020 | 65 | 6 paper copies of the Corrected Amicus Brief [46] received from Amicus Curiae Biotechnology Innovation Organization. [708610] [CJF] [Entered: 07/20/2020 03:57 PM] (0) |
| Jul 17, 2020 | 64 | 6 paper copies of the Confidential Appendix (Vol. I - III) [56] received from Appellants Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Limited. [708607] [CJF] [Entered: 07/20/2020 03:56 PM] (0) |
| Jul 17, 2020 | 63 | Notice from Appellants Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Limited regarding conflicts with oral argument. None. Service: 07/17/2020 by email. [708240] [20-1723] [Jonathan Singer] [Entered: 07/17/2020 11:21 AM] (1) |
| Jul 15, 2020 | 66 | 6 paper copies of the Opening Response Brief [49] received from Appellees Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Hikma Pharmaceuticals International Limited and Hikma Pharmaceuticals USA Inc. [708614] [CJF] [Entered: 07/20/2020 04:04 PM] (0) |
| Jul 15, 2020 | 62 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: re: Doc No. [60], Doc No. [61], ERROR: The case number is incomplete. CORRECTION: For all future filings, please include all consolidated case numbers. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [707736] [EKD] [Entered: 07/15/2020 12:05 PM] (0) |
| Jul 14, 2020 | 61 | Amended Entry of appearance for Jonathan E. Singer as counsel for Appellants Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Limited. Service: 07/14/2020 by email. [707538] [20-1723] [Jonathan Singer] [Entered: 07/14/2020 06:42 PM] (1) |
| Jul 14, 2020 | 60 | Amended Entry of appearance for Oliver J. Richards as counsel for. Service: 07/14/2020 by email. [707456] [20-1723] [Oliver Richards] [Entered: 07/14/2020 03:16 PM] (1) |
| Jul 13, 2020 | 59 | The Clerk's Office directs that outstanding paper copies of all briefs and appendices in this case must be submitted on or before July 20, 2020. See Administrative Order No. 20-01 (Mar. 20, 2020). [707082] [LMN] [Entered: 07/13/2020 02:55 PM] (0) |
| Jul 13, 2020 | 58 | Notice to Advise of Scheduling Conflicts. Arguing counsel must advise of, and show good cause for, any scheduling conflicts during the upcoming court session months listed in the attached notice. The Response to Notice to Advise of Scheduling Conflicts can be found here. The Oral Argument Guide can be found here. [707077] [LMN] [Entered: 07/13/2020 02:48 PM] (1) |
| Jul 13, 2020 | 57 | ORDER filed granting [704056-2] the motion. Appeal Nos. 2020-1723 and 2020-1901 are consolidated, and the revised official caption is reflected above. The consolidated appeals are fully briefed and ready for calendaring. A copy of this order and the motion papers shall be transmitted to the merits panel assigned to this case. Service as of this date by the Clerk of Court. [706907] [20-1723, 20-1901] [LMS] [Entered: 07/13/2020 09:07 AM] (3) |
| Jul 1, 2020 | 56 | MODIFIED ENTRY: CONFIDENTIAL APPENDIX FILED for Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Limited. Number of Pages: 1523. Service: 07/01/2020 by email. [705067]--[Edited 07/13/2020 by LMN - compliance review complete] [Jonathan Singer] [Entered: 07/01/2020 09:55 PM] (0) |
| Jul 1, 2020 | 55 | MODIFIED ENTRY: APPENDIX FILED for Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Limited. Number of Pages: 1523. Service: 07/01/2020 by email. [705066] --[Edited 07/13/2020 by LMN - compliance review complete] [Jonathan Singer] [Entered: 07/01/2020 09:45 PM] (1523) |
| Jul 1, 2020 | 54 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellees Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd.. Service: 07/01/2020 by email. [705058] [20-1723] [Constance Huttner] [Entered: 07/01/2020 07:13 PM] (3) |
| Jul 1, 2020 | 53 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellees Hikma Pharmaceuticals International Limited and Hikma Pharmaceuticals USA Inc.. Service: 07/01/2020 by email. [705049] [20-1723] [Charles Klein] [Entered: 07/01/2020 06:14 PM] (2) |
| Jul 1, 2020 | 52 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellants Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Limited. Service: 07/01/2020 by email. [704947] [20-1723] [Deanna Reichel] [Entered: 07/01/2020 02:24 PM] (3) |
| Jul 1, 2020 | 51 | Joint Statement of Compliance with Fed. Cir. R. 33 for Appellants Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited and Appellees Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Hikma Pharmaceuticals International Limited and Hikma Pharmaceuticals USA Inc.. Service: 07/01/2020 by email. [704939] [20-1723] [Deanna Reichel] [Entered: 07/01/2020 02:14 PM] (4) |
| Jun 26, 2020 | 50 | MODIFIED ENTRY: REPLY BRIEF FILED for Appellants Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Limited. Number of Pages: 30. Service: 06/26/2020 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [704108] --[Edited 07/01/2020 by LMN - compliance review complete] [Jonathan Singer] [Entered: 06/26/2020 04:07 PM] (40) |
| Jun 16, 2020 | 47 | Amended Certificate of Interest for Appellees Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd.. Service: 06/16/2020 by email. [701681] [20-1723] [Constance Huttner] [Entered: 06/16/2020 06:48 PM] (2) |
| Jun 16, 2020 | 48 | Amended Certificate of Interest for Appellees Hikma Pharmaceuticals International Limited and Hikma Pharmaceuticals USA Inc.. Service: 06/16/2020 by email. [701691] [20-1723] [Charles Klein] [Entered: 06/16/2020 09:36 PM] (3) |
| Jun 16, 2020 | 49 | MODIFIED ENTRY: RESPONSE BRIEF FILED for Appellees Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Hikma Pharmaceuticals International Limited and Hikma Pharmaceuticals USA Inc. Number of Pages: 65. Service: 06/16/2020 by email. [701700] --[Edited 07/01/2020 by LMN - compliance review complete] [Charles Klein] [Entered: 06/16/2020 11:44 PM] (81) |
| May 20, 2020 | 46 | MODIFIED ENTRY: CORRECTED AMICUS BRIEF FILED for Biotechnology Innovation Organization. Pages: 19. Service: 05/20/2020 by email. [696016]--[Edited 05/21/2020 by LMN - compliance review complete] [Rachel Elsby] [Entered: 05/20/2020 06:18 PM] (29) |
| May 20, 2020 | 45 | Notice of Correction to Doc No. [43] for Amicus Curiae Biotechnology Innovation Organization. Service: 05/20/2020 by email. [696015] [20-1723] [Rachel Elsby] [Entered: 05/20/2020 06:14 PM] (5) |
| May 20, 2020 | 44 | NOTICE OF NON-COMPLIANCE: The submission of Amicus Curiae Biotechnology Innovation Organization, Amicus Curiae Brief [39], is not in compliance with the rules of this court (see attached). Compliant document is due on 05/28/2020. Service as of this date by the Clerk of Court. [695988] [LMN] [Entered: 05/20/2020 04:16 PM] (1) |
| May 19, 2020 | 43 | MODIFIED ENTRY: AMICUS BRIEF FILED for Aimed Alliance. Pages: 26. Service: 05/19/2020 by email. [695791]--[Edited 05/20/2020 by LMN - compliance review complete] [Ashley Parrish] [Entered: 05/19/2020 06:28 PM] (36) |
| May 19, 2020 | 42 | Entry of appearance for Jesse Snyder as of counsel for Aimed Alliance. Service: 05/19/2020 by email. [695786] [20-1723] [Jesse Snyder] [Entered: 05/19/2020 06:22 PM] (2) |
| May 19, 2020 | 41 | Entry of appearance for Paul Alessio Mezzina as of counsel for Aimed Alliance. Service: 05/19/2020 by email. [695785] [20-1723] [Paul Mezzina] [Entered: 05/19/2020 06:18 PM] (2) |
| May 19, 2020 | 40 | Certificate of Interest for Aimed Alliance. Service: 05/19/2020 by email. [695782] [20-1723] [Ashley Parrish] [Entered: 05/19/2020 05:59 PM] (3) |
| May 19, 2020 | 39 | FILED from Biotechnology Innovation Organization Title: AMICUS CURIAE BRIEF. Service: 05/19/2020 by email. [695781] [20-1723] This document is non-compliant. See Doc No. [44] [Rachel Elsby] [Entered: 05/19/2020 05:59 PM] (28) |
| May 19, 2020 | 38 | Entry of appearance for Ashley C. Parrish as principal counsel for Aimed Alliance. Service: 05/19/2020 by email. [695780] [20-1723] [Ashley Parrish] [Entered: 05/19/2020 05:57 PM] (2) |
| May 19, 2020 | 37 | Entry of appearance for Hans Sauer as of counsel for Biotechnology Innovation Organization. Service: 05/19/2020 by email. [695779] [20-1723] [Rachel Elsby] [Entered: 05/19/2020 05:48 PM] (2) |
| May 19, 2020 | 36 | Entry of appearance for Melissa Brand as of counsel for Biotechnology Innovation Organization. Service: 05/19/2020 by email. [695778] [20-1723] [Rachel Elsby] [Entered: 05/19/2020 05:43 PM] (2) |
| May 19, 2020 | 35 | Entry of appearance for Jason Weil as of counsel for Biotechnology Innovation Organization. Service: 05/19/2020 by email. [695776] [20-1723] [Rachel Elsby] [Entered: 05/19/2020 05:38 PM] (2) |
| May 19, 2020 | 34 | Entry of appearance for Rachel J. Elsby as principal counsel for Biotechnology Innovation Organization. Service: 05/19/2020 by email. [695775] [20-1723] [Rachel Elsby] [Entered: 05/19/2020 05:35 PM] (2) |
| May 18, 2020 | 33 | ORDER filed. Amarin’s motion is granted [8] to the extent that Amarin’s opening brief is due no later than May 12, 2020, Appellees’ response brief(s) are due no later than June 16, 2020, Amarin’s reply brief is due no later than June 26, 2020, and the joint appendix is due no later than July 1, 2020. The appeal will be placed on the next available oral argument calendar once briefing is complete. Hikma’s motion is granted [28] to the extent that the revised official caption is reflected in the order. Service as of this date by the Clerk of Court. [695259] [NL] [Entered: 05/18/2020 11:43 AM] (2) |
| May 12, 2020 | 32 | MODIFIED ENTRY: CORRECTED BRIEF FILED for Appellants Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Limited. Number of Pages: 72. Service: 05/12/2020 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [694092] --[Edited 05/19/2020 by LMN - compliance review complete] [Jonathan Singer] [Entered: 05/12/2020 06:18 PM] (282) |
| May 12, 2020 | 31 | Notice of Correction to Doc No. [30] for Appellants Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Limited. Service: 05/12/2020 by email. [694091] [20-1723] [Jonathan Singer] [Entered: 05/12/2020 06:14 PM] (3) |
| May 12, 2020 | 30 | FILED from Appellants Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Limited. Title: OPENING BRIEF. Service: 05/12/2020 by email. This document has been corrected. See doc. [32] [694048] [20-1723]--[Edited 05/19/2020 by LMN] [Jonathan Singer] [Entered: 05/12/2020 04:09 PM] (74) |
| May 1, 2020 | 29 | Entry of appearance for Caroline Sun as of counsel for Appellees Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd.. Service: 05/01/2020 by email. [691719] [20-1723] [Caroline Sun] [Entered: 05/01/2020 03:21 PM] (2) |
| May 1, 2020 | 28 | MOTION of Appellees West-Ward Pharmaceuticals International Limited and Hikma Pharmaceuticals USA Inc. to modify the official caption [Consent: unopposed]. Service: 05/01/2020 by email. [691561] [20-1723] [Charles Klein] [Entered: 05/01/2020 10:22 AM] (10) |
| Apr 30, 2020 | 27 | Corrected Certificate of Interest for Appellees Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd.. Service: 04/30/2020 by email. [691123] [20-1723] [Constance Huttner] [Entered: 04/30/2020 09:40 AM] (3) |
| Apr 28, 2020 | 26 | Entry of appearance for James P. Barabas as of counsel for Appellees Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd.. Service: 04/28/2020 by email. [690562] [20-1723] [James Barabas] [Entered: 04/28/2020 03:05 PM] (2) |
| Apr 28, 2020 | 25 | Entry of appearance for Beth Finkelstein as of counsel for Appellees Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd.. Service: 04/28/2020 by email. [690560] [20-1723] [Beth Finkelstein] [Entered: 04/28/2020 03:02 PM] (2) |
| Apr 28, 2020 | 24 | Certificate of Interest for Appellees Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd.. Service: 04/28/2020 by email. [690556] [20-1723] [Constance Huttner] [Entered: 04/28/2020 02:59 PM] (3) |
| Apr 28, 2020 | 23 | Docketing Statement for the Appellees Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd.. Service: 04/28/2020 by email. [690553] [20-1723] [Constance Huttner] [Entered: 04/28/2020 02:57 PM] (3) |
| Apr 28, 2020 | 22 | Entry of appearance for Constance S. Huttner as principal counsel for Appellees Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd.. Service: 04/28/2020 by email. [690550] [20-1723] [Constance Huttner] [Entered: 04/28/2020 02:54 PM] (2) |
| Apr 27, 2020 | 21 | Corrected Entry of appearance for Eric Sonnenschein as of counsel for Appellant Amarin Pharma, Inc.. Service: 04/27/2020 by email. [690368] [20-1723] [Eric Sonnenschein] [Entered: 04/27/2020 04:56 PM] (2) |
| Apr 27, 2020 | 20 | Corrected Entry of appearance for Jeffrey Elikan as of counsel for Appellant Amarin Pharma, Inc.. Service: 04/27/2020 by email. [690364] [20-1723] [Christopher Sipes] [Entered: 04/27/2020 04:46 PM] (2) |
| Apr 27, 2020 | 19 | Corrected Entry of appearance for Christopher Sipes as of counsel for Appellant Amarin Pharma, Inc.. Service: 04/27/2020 by email. [690360] [20-1723] [Christopher Sipes] [Entered: 04/27/2020 04:36 PM] (2) |
| Apr 27, 2020 | 18 | NOTICE OF NON-COMPLIANCE: The submission of Appellants Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Limited, Entries of Appearance [9], [10], [11], is not in compliance with the rules of this court (see attached). Compliant documents are due on 05/04/2020. Service as of this date by the Clerk of Court. [690250] [LMN] [Entered: 04/27/2020 02:26 PM] (2) |
| Apr 24, 2020 | 17 | Entry of appearance for Eimeric Reig-Plessis as of counsel for Appellees West-Ward Pharmaceuticals International Limited and Hikma Pharmaceuticals USA Inc.. Service: 04/24/2020 by email. [689811] [20-1723] [Eimeric Reig-Plessis] [Entered: 04/24/2020 12:59 PM] (2) |
| Apr 24, 2020 | 16 | Entry of appearance for Alison M. Heydorn as of counsel for Appellees West-Ward Pharmaceuticals International Limited and Hikma Pharmaceuticals USA Inc.. Service: 04/24/2020 by email. [689809] [20-1723] [Alison Heydorn] [Entered: 04/24/2020 12:57 PM] (2) |
| Apr 24, 2020 | 15 | Entry of appearance for Claire A. Fundakowski as of counsel for Appellees West-Ward Pharmaceuticals International Limited and Hikma Pharmaceuticals USA Inc.. Service: 04/24/2020 by email. [689805] [20-1723] [Claire Fundakowski] [Entered: 04/24/2020 12:53 PM] (2) |
| Apr 24, 2020 | 14 | Certificate of Interest for Appellees West-Ward Pharmaceuticals International Limited and Hikma Pharmaceuticals USA Inc.. Service: 04/24/2020 by email. [689803] [20-1723] [Charles Klein] [Entered: 04/24/2020 12:51 PM] (4) |
| Apr 24, 2020 | 13 | Docketing Statement for the Appellees West-Ward Pharmaceuticals International Limited and Hikma Pharmaceuticals USA Inc.. Service: 04/24/2020 by email. [689800] [20-1723] [Charles Klein] [Entered: 04/24/2020 12:49 PM] (4) |
| Apr 24, 2020 | 12 | Entry of appearance for Charles B. Klein as principal counsel for Appellees West-Ward Pharmaceuticals International Limited and Hikma Pharmaceuticals USA Inc.. Service: 04/24/2020 by email. [689797] [20-1723] [Charles Klein] [Entered: 04/24/2020 12:45 PM] (2) |
| Apr 24, 2020 | 11 | Entry of appearance for Christopher Sipes as of counsel for Appellant Amarin Pharma, Inc.. Service: 04/24/2020 by email. [689739] [20-1723] This document is non-compliant. See Doc No.[18] [Christopher Sipes] [Entered: 04/24/2020 11:10 AM] (2) |
| Apr 24, 2020 | 10 | Entry of appearance for Jeffrey Elikan as of counsel for Appellant Amarin Pharma, Inc.. Service: 04/24/2020 by email. [689737] [20-1723] This document is non-compliant. See Doc No.[18] [Jeffrey Elikan] [Entered: 04/24/2020 11:05 AM] (2) |
| Apr 24, 2020 | 9 | Entry of appearance for Eric Sonnenschein as of counsel for Appellant Amarin Pharma, Inc.. Service: 04/24/2020 by email. [689729] [20-1723] This document is non-compliant. See Doc No.[18] [Eric Sonnenschein] [Entered: 04/24/2020 10:53 AM] (2) |
| Apr 22, 2020 | 8 | MOTION of Appellants Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Limited to expedite briefing schedule, to expedite hearing [Consent: unopposed]. Service: 04/22/2020 by email. [689057] [20-1723] [Jonathan Singer] [Entered: 04/22/2020 10:23 AM] (7) |
| Apr 21, 2020 | 7 | Entry of appearance for Oliver Richards as of counsel for Appellants Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Limited. Service: 04/21/2020 by email. [688767] [20-1723] [Oliver Richards] [Entered: 04/21/2020 02:11 PM] (2) |
| Apr 21, 2020 | 6 | Entry of appearance for Nitika Gupta Fiorella as of counsel for Appellants Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Limited. Service: 04/21/2020 by email. [688765] [20-1723] [Nitika Gupta Fiorella] [Entered: 04/21/2020 02:07 PM] (2) |
| Apr 21, 2020 | 5 | Entry of appearance for Deanna J. Reichel as of counsel for Appellants Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Limited. Service: 04/21/2020 by email. [688762] [20-1723] [Deanna Reichel] [Entered: 04/21/2020 02:03 PM] (2) |
| Apr 21, 2020 | 4 | Docketing Statement for the Appellants Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Limited. Service: 04/21/2020 by email. [688761] [20-1723] [Jonathan Singer] [Entered: 04/21/2020 02:00 PM] (3) |
| Apr 21, 2020 | 3 | Certificate of Interest for Appellants Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Limited. Service: 04/21/2020 by email. [688760] [20-1723] [Jonathan Singer] [Entered: 04/21/2020 01:57 PM] (3) |
| Apr 21, 2020 | 2 | Entry of appearance for Jonathan E. Singer as principal counsel for Appellants Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Limited. Service: 04/21/2020 by email. [688758] [20-1723] [Jonathan Singer] [Entered: 04/21/2020 01:55 PM] (2) |
| Apr 21, 2020 | 1 | Appeal docketed. Received: 04/14/2020. [688590]Entry of Appearance is due 05/05/2020. Certificate of Interest is due on 05/05/2020. Docketing Statement is due 05/05/2020. Appellant's brief is due 06/22/2020. [LMN] [Entered: 04/21/2020 09:54 AM] (268) |
